Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Telmitar 80 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Telmitar 80

Approved

STANDARD

Telmitar 80

Hetero Labs Limited (Unit V)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: c6a45e9fcf8f9dbf
Company: Hetero Labs Limited (Unit V)
Type: Standard

Approval Details

Approval Id: c6a45e9fcf8f9dbf
Drug Approval Philippines Name: Telmitar 80
Product Name: Telmitar 80
Registration Number: DRP-10424
Brand Name: Telmitar 80
Generic Name: Telmisartan
Dosage Form: Tablet
Dosage Strength: 80mg
Manufacturer: Hetero Labs Limited (Unit V)
Importer: Camber Pharmaceuticals, Inc.
Distributor: Camber Pharmaceuticals, Inc.
Importer Detail Path: /organization/camber-pharmaceuticals-inc
Distributor Detail Path: /organization/camber-pharmaceuticals-inc
Issuance Date: 25 October 2021
Expiry Date: 25 October 2026
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

c6a45e9fcf8f9dbf

Type

Standard

Back to Philippines FDA Approvals